Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

MLA

López-Pousa, A., et al. “Phase I/II Trial of Doxorubicin and Fixed Dose-Rate Infusion Gemcitabine in Advanced Soft Tissue Sarcomas: A GEIS Study.” British Journal of Cancer, vol. 94, no. 12, June 2006, pp. 1797–802. EBSCOhost, https://doi.org/10.1038/sj.bjc.6603187.

APA

López-Pousa, A., Losa, R., Martín, J., Maurel, J., Fra, J., Sierra, M., Casado, A., García del Muro, J., Poveda, A., Balañá, C., Martínez-Trufero, J., Esteban, E., Buesa, J. M., López-Pousa, A., Martín, J., García Del Muro, J., Balañá, C., & Martínez-Trufero, J. (2006). Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. British Journal of Cancer, 94(12), 1797–1802. https://doi.org/10.1038/sj.bjc.6603187

Chicago

López-Pousa, A., R. Losa, J. Martín, J. Maurel, J. Fra, M. Sierra, A. Casado, et al. 2006. “Phase I/II Trial of Doxorubicin and Fixed Dose-Rate Infusion Gemcitabine in Advanced Soft Tissue Sarcomas: A GEIS Study.” British Journal of Cancer 94 (12): 1797–1802. doi:10.1038/sj.bjc.6603187.